Mark Zuckerberg: Facebook Chairman & CEO

Mark Zuckerberg was born on May 14, 1984, in White Plains, New York.  He is the son of a dentist father and a psychiatrist mother. Mark excelled in his academics in high school. In middle school he began using computers and coding. 

It is reported by the time he entered Harvard University he already achieved a reputation as a programming prodigy. While in college he co-founded with five other people the social networking website, Facebook. They launched Facebook from Harvard University’s dormitory rooms. They then launched Facebook onto other campuses nationwide and moved to Palo Alto, California shortly thereafter. 

When Mark was 23 years old in 2007, he became a billionaire riding on the success of Facebook. In 2012, the number of Facebook users climbed to a total of one billion. Mark was also involved in a number of legal disputes that were started by others in the group, who claimed a share of the company based on their involvement during he development phase of Facebook. 

He sits as chairman and CEO of Facebook ,earning a CEO salary of one dollar. His net worth though as of July 2015, was estimated at $38.6 billion.

Robert Bradway: Amgen CEO

Robert Bradway earned a degree in Biology from Amherst College and later earned an MBA from Harvard University. He joined Morgan Stanley in New York in 1985 as a health care industry investment banker. In 1990 Robert moved to London and served as head of the international health care investment banking activities of Morgan Stanley. He later was responsible for corporate finance management. 

Robert was Managing Director for banking department and corporate finance Europe, for Morgan Stanley in London after which he left the company and joined Amgen in 2006. He came into Amgen as Vice President, Operations Strategy. Robert was then promoted and became Vice President and Chief Financial Officer on April 2007. He served in that capacity until May 2010 when he was appointed President and Chief Operating Officer. 

Robert was appointed to the Amgen Board of Directors in 2011.  He became Chief Executive Officer in May 2012 and Chairman in January 2013. Robert is a member of the Board of Directors of Norfolk Southern Corporation and serves on its Audit and Governance committees. 

The company that Robert leads is one of the largest publicly traded in the world. It was founded in April 8, 1980, by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmannn and Joseph Rubinfeld. Amgen is based in Thousand Oaks, California. 

The biotechnology medicines company discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

The company markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. Amgen’s products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor both of which  selectively stimulate the production of neutrophils; Embrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body’s response to inflammatory diseases; and other products. 

With a background in biology, Robert has a clear understanding of the complex and advanced work his company does and not merely relying on his management and financial knowhow. 

Michael Corbat: Citigroup CEO

Michael Corbat was born on May 2, 1960 in Bristol, Connecticut, USA. He earned a B.A. in economics from Harvard University. Michael was also interested in sports and played offensive guard for the school’s football team. He was two time all Ivy League and was selected as first string College Football All-American Team in NCCA Division I-AA in 1982. Michael was good enough to be drafted professionally but passed up the chance to work in Wall Street.

He began working at Solomon Brothers and didn’t leave when it was acquired by Citi.  At the end of the day company ownership did not affect his rise to the top post. Among the roles he assumed was as Head of Citi’s Global Corporate Bank and Global Commercial Bank and CEO of Citi’s Global Wealth Management.

Michael was also CEO of Citi Holdings and was responsible for and led the divestiture of a portfolio of non-core business and assets following the financial crisis of 2008 and Citi’s participation in the Troubled Asset Relief Program. He was named CEO of Europe, Middle East and Africa (EMEA) in 2011. Michael became CEO of Citi in October 2012.

Citi is one of the largest banks in the world with around 200 million customer accounts and activities in over 160 countries and jurisdictions.